Creation of a safe, effective, economical, and patient-friendly drug delivery interface has been an ongoing endeavor undertaken by the pharmaceutical industry. Medicinal chemists and biologists have the critical task of discovering and developing novel mechanisms that can address unmet medical needs by treating diseases with greater safety and convenience-enabling drug delivery platforms. Pharmaceutical and biotechnology companies are increasingly focused upon optimizing administration methods to increase the effectiveness of treatment and improve overall patient compliance. However, most of these developments have been tiny evolutionary changes- smaller needles and more attractive design.
One notable quantum leap in technology to address the issues associated with sub-optimal drug delivery is occurring at the University of Florida’s award-winning Sid Martin Biotechnology Incubator. Prometheon Pharma LLC has adopted a fundamentally different approach to transdermal drug delivery through its TopiconTM patch technology.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly